相关实验视频
Updated: Jun 6, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.5K
根据GINA 2023的喘控制:改变标准是否可以改善喘控制?
Ebymar Arismendi1,2, Paula Ribo1, Alberto García2
1Pulmonology Department, Hospital Clínic, Universitat de Barcelona, 08036 Barcelona, Spain.
Journal of clinical medicine
|November 27, 2024
概括
更新的喘指南 (GINA 2023) 重新分类了许多以前被认为无法控制的患者. 这凸显了不断变化的定义如何影响喘管理和控制评估.
科学领域:
- 肺部病理学 肺部病理学
- 临床医学 临床医学
- 呼吸系统健康 呼吸系统健康
背景情况:
- 有效控制喘对于预防恶化和长期风险至关重要.
- 在临床指南中喘控制定义的差异可能会影响患者管理.
- 全球喘倡议 (GINA) 的指导方针已经更新,需要对喘控制分类进行审查.
研究的目的:
- 通过GINA 2023标准评估喘控制模式.
- 根据更新的GINA 2023指南,重新分类以前无法控制的喘患者.
- 评估修订后的GINA标准对喘控制定义的影响.
主要方法:
- 来自COAS研究的1299名患者的分析,这是一个横截面的多中心研究.
- 根据GINA 2010指南,患者最初被归类为不受控制的.
- 使用GINA 2023喘控制标准对患者进行重新分类.
主要成果:
- 根据GINA 2023,大量以前未经控制的喘患者被重新分类为受控制 (24.3%) 或部分控制 (16.3%).
- 59.4%的患者保留了他们不受控制的喘分类.
- 喘控制测试 (ACT) 评分,吸烟状况,过敏性鼻炎和肺功能在重新分类后保持一致.
结论:
- 临床指南定义的变化大大改变了对控制喘的看法.
- 在GINA 2023标准中排除肺功能异常导致控制喘患者的百分比显著增加.
- 更新的GINA 2023指南提供了对喘控制评估的修订视角.
相关概念视频
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
218
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
218
01:30Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237